Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and Inflammation

oxazoles has been researched along with Inflammation in 50 studies

Research

Studies (50)

TimeframeStudies, this research(%)All Research%
pre-199018 (36.00)18.7374
1990's2 (4.00)18.2507
2000's9 (18.00)29.6817
2010's18 (36.00)24.3611
2020's3 (6.00)2.80

Authors

AuthorsStudies
Chen, W; Fang, H; Hong, Z; Jin, W; Li, L; Yang, L; Yi, Z; Zhang, G; Zhang, Y1
Fu, M; Hao, K; Li, S; Liu, Y; Yang, Q; Yang, X; Zhou, Z1
Cao, M; Chen, D; Han, X; Ji, F; Liufu, N; Yao, W; Zeng, Q1
Ochani, M; Sharma, A; Wang, P; Yang, WL1
Radulović, NS; Randjelović, PJ; Stojanović, NM; Todorovska, MM; Zlatković, DB1
Cordaro, M; Crupi, R; Cuzzocrea, S; D'Amico, R; Di Paola, R; Gugliandolo, E; Impellizzeri, D; Peritore, AF; Siracusa, R1
Brennan, E; Butler, E; Cacace, A; Chen, J; de Gaetano, M; Fallon, P; Gahan, K; Godson, C; Guiry, PJ; Hams, E; Leroy, X; Loscher, CE; Maingot, C; Marai, M; McLoughlin, A; Perretti, M; Zanetti, A1
Cordaro, M; Crupi, R; Cuzzocrea, S; D'Amico, R; Di Paola, R; Evangelista, M; Gugliandolo, E; Impellizzeri, D; Peritore, AF; Petrosino, S; Siracusa, R1
Asmawi, MZ; Aulaskari, PH; Kolmonen, A; Leppänen, T; Lindholm, M; Moilanen, E; Paukkeri, EL; Yam, MF1
Bai, L; Ji, M; Lin, R; Lu, Y; Qiao, H; Ren, F; Wang, W; Yang, L; Zhang, J1
Bevaart, L; Clark, R; Elbaum, D; Koepke, J; Koopman, FA; Lamppu, D; LaRosa, GJ; Papke, RL; Tak, PP; van Maanen, MA; Vervoordeldonk, MJ1
Han, JW; Jang, CH; Ji, YE; Kang, TB; Koppula, S; Lee, KH; Shim, DW; Shin, HJ1
Ann, SJ; Chung, JH; Jang, J; Kang, SM; Kim, SH; Lee, SH; Park, BH; Park, S1
Cho, YS; Suh, JH; Yum, EK1
Calabriso, N; Carluccio, MA; De Caterina, R; Massaro, M; Pellegrino, M; Scoditti, E; Storelli, C; Wabitsch, M; Wright, M1
Alfonsi, D; Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Impellizzeri, D; Marcolongo, G; Pascali, J1
Cruz, HG; Dingemanse, J; Groenen, PM; Krause, A; Lott, D; Stalder, AK; Strasser, DS1
Burnstock, G; Fan, J; Jiang, Q; Li, WX; Ma, B; Sun, JR; Yang, H; Yu, LH; Zhu, TT1
Cancedda, FD; Cancedda, R; Ulivi, V1
Chapman, V; Kendall, DA; Sagar, DR1
Okamoto, T; Park, CH; Toriizuka, K; Yamabe, N; Yokozawa, T1
Fujii, G; Komiya, M; Mutoh, M; Noma, N; Shimura, M; Takahashi, M; Tanuma, S; Yamamoto, M; Yanaka, A1
Gyires, K; Mátyus, P; Mérey, A; Szökő, E; Tábi, T; Tóth, V1
FROMMEL, E; RADOUCO-THOMAS, S; WILDER SMITH, AE1
CAVALLINI, G; MASSARANI, E; MAURI, L; NARDI, D1
GISSELBRECHT, H; LONGCHAMP, D1
Sakurai, H; Schwabe, RF1
Brandt, MR; Cummons, TA; Harris, HA; Leventhal, L; Piesla, MJ; Rogers, KE1
Cvoro, A; Harris, HA; Leitman, DC; Tatomer, D; Tee, MK; Zogovic, T1
Rathna, GV1
Belvisi, MG; Birrell, MA; Catley, MC; de Alba, J; Farrow, S; Haj-Yahia, S; Hardaker, EL1
Aliaga, M; Barbara, M; Bru, M; Caillol, V; Lauressergues, H; Tarayre, JP; Villanova, G1
Berkenkoph, J; Fernandez, X; Friary, R; Green, MJ; Lutsky, BN; Monahan, M; Tiberi, RL1
English, D; Garcia, JG; Herenyiova, M; Verin, AD1
Boehringer, N; Hagens, G; Isler, P; Nicod, LP; Songeon, F1
Iwamura, H; Matsushita, M; Tazaki, H; Wakitani, K1
Asarnow, D; Dinter, H; Esperling, P; Faulds, D; Halks-Miller, M; Kirsch, G; Laurent, H; Mitrovic, B; Onuffer, J; Ottow, E; Perez, HD; Schneider, H; Seidelmann, D; Tse, J; Tuohy, VK; Wachtel, H1
Dent, RW; Ervin, DK1
Parrott, DM; Rose, ML1
DiPasquale, G; Gingold, J; Rassaert, C; Richter, R; Singer, R; Welaj, P1
Humes, JL; Meurer, R; Opas, EE1
Hirschelmann, R; Schade, R1
Allwood, GG; Asherson, GL1
Parker, D; Poulter, LW; Turk, JL1
Bates, HM; Berger, FM; Diamantis, W; Kletzkin, M; Plekss, OJ; Sofia, RD; Spencer, HJ1
Scribner, JD; Slaga, TJ1
Jones, JV; Wallington, TB1
Bertaccini, G; Impicciatore, M; Vitali, T1
Green, AY; Green, D1
Iizuka, Y; Kamioka, T; Kobayashi, S; Kumakura, S; Takagi, H1

Trials

2 trial(s) available for oxazoles and Inflammation

ArticleYear
Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:3

    Topics: Adolescent; Adult; Animals; Biomarkers; Cell Migration Assays; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Inflammation; Lipopolysaccharides; Male; Middle Aged; Neutrophils; Oxazoles; Receptors, Formyl Peptide; Receptors, Lipoxin; Triazoles; Young Adult

2017
A study of metaxalone (Skelaxin) vs. placebo in acute musculoskeletal disorders: a cooperative study.
    Current therapeutic research, clinical and experimental, 1975, Volume: 18, Issue:3

    Topics: Anthropometry; Clinical Trials as Topic; Drug Evaluation; Humans; Inflammation; Muscular Diseases; Oxazoles; Oxazolidinones; Pain; Placebos; Spasm; Wounds and Injuries

1975

Other Studies

48 other study(ies) available for oxazoles and Inflammation

ArticleYear
Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
    Marine drugs, 2020, Apr-21, Volume: 18, Issue:4

    Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; beta Carotene; Cytokines; Enzyme Inhibitors; Ethanolamines; Inflammation; Lipopolysaccharides; Mice; Nitric Oxide; Oxazoles; Palmitic Acids; PPAR alpha; RAW 264.7 Cells; Tyrosine

2020
HDAC6 inhibitor Cay10603 inhibits high glucose-induced oxidative stress, inflammation and apoptosis in retinal pigment epithelial cells via regulating NF-κB and NLRP3 inflammasome pathway.
    General physiology and biophysics, 2020, Volume: 39, Issue:2

    Topics: Apoptosis; Carbamates; Epithelial Cells; Glucose; Histone Deacetylase Inhibitors; Humans; Inflammasomes; Inflammation; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxazoles; Oxidative Stress; Reactive Oxygen Species; Retina

2020
MG53 Protects against Sepsis-Induced Myocardial Dysfunction by Upregulating Peroxisome Proliferator-Activated Receptor-
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Animals; Apoptosis; Humans; Inflammation; Models, Biological; Muscle Proteins; Myocardium; Myocytes, Cardiac; Oxazoles; Oxidative Stress; PPAR alpha; Protective Agents; Rats, Sprague-Dawley; Sepsis; Survival Analysis; Tyrosine; Up-Regulation; Vesicular Transport Proteins

2020
Mitigation of sepsis-induced inflammatory responses and organ injury through targeting Wnt/β-catenin signaling.
    Scientific reports, 2017, 08-23, Volume: 7, Issue:1

    Topics: Animals; Apoptosis; Cytokines; Disease Models, Animal; Inflammation; Inflammation Mediators; Lipopolysaccharides; Lung; Macrophage Activation; Macrophages; Mice; Neutrophil Infiltration; Oxazoles; RAW 264.7 Cells; Sepsis; Wnt Signaling Pathway

2017
Two goitrogenic 1,3-oxazolidine-2-thione derivatives from Brassicales taxa: Challenging identification, occurrence and immunomodulatory effects.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2017, Volume: 110

    Topics: Animals; Brassicaceae; Chromatography, Gas; Humans; Immunologic Factors; Inflammation; Magnetic Resonance Spectroscopy; Molecular Structure; Oxazoles; Plant Extracts; Rats; Rats, Wistar; Stereoisomerism; Thiones

2017
2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease.
    Molecular neurobiology, 2018, Volume: 55, Issue:12

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Astrocytes; Behavior, Animal; Cyclooxygenase 2; Cytokines; Disease Models, Animal; DNA Damage; Dopamine Plasma Membrane Transport Proteins; Inflammation; Mice, Inbred C57BL; Microglia; NF-E2-Related Factor 2; Nitric Oxide Synthase Type II; Nitrosative Stress; Oxazoles; Oxidative Stress; Parkinson Disease; Poly Adenosine Diphosphate Ribose; Transcription Factor RelA; Tyrosine; Tyrosine 3-Monooxygenase

2018
Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A
    European journal of medicinal chemistry, 2019, Jan-15, Volume: 162

    Topics: Animals; Cell Line; Humans; Imidazoles; Inflammation; Lipoxins; Mice; Molecular Mimicry; Monocytes; NF-kappa B; Oxazoles; Peritonitis; Receptors, Formyl Peptide

2019
N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion.
    Neurobiology of disease, 2019, Volume: 125

    Topics: Amidohydrolases; Animals; Anti-Inflammatory Agents; Apoptosis; Carotid Stenosis; Dementia, Vascular; Disease Models, Animal; Inflammation; Male; Mice; Neuroprotective Agents; Oxazoles; Oxidative Stress

2019
Anti-inflammatory properties of a dual PPARgamma/alpha agonist muraglitazar in in vitro and in vivo models.
    Arthritis research & therapy, 2013, Apr-17, Volume: 15, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Gene Expression; Glycine; HEK293 Cells; Humans; In Vitro Techniques; Inflammation; Macrophages; Mice; Oxazoles; PPAR alpha; PPAR gamma; Real-Time Polymerase Chain Reaction

2013
The protective effect of fenofibrate against TNF-α-induced CD40 expression through SIRT1-mediated deacetylation of NF-κB in endothelial cells.
    Inflammation, 2014, Volume: 37, Issue:1

    Topics: Acetylation; Antioxidants; Benzamides; CD40 Antigens; Cells, Cultured; Fenofibrate; Human Umbilical Vein Endothelial Cells; Humans; Hypolipidemic Agents; Inflammation; Naphthols; Niacinamide; Oxazoles; PPAR alpha; Pyrrolidines; RNA Interference; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Thiocarbamates; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation

2014
Two novel α7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in mice.
    PloS one, 2015, Volume: 10, Issue:1

    Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Anilides; Animals; Arthritis, Experimental; Cell Line; Inflammation; Knee Joint; Ligands; Mice; Mice, Inbred Strains; Oxazoles; PC12 Cells; Piperazines; Pyridines; Rats; Signal Transduction; Xenopus

2015
A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
    Toxicology and applied pharmacology, 2015, Apr-15, Volume: 284, Issue:2

    Topics: Acute Lung Injury; Adaptor Proteins, Vesicular Transport; Animals; Anti-Inflammatory Agents; Cell Line; Cyclooxygenase 2; Disease Models, Animal; Female; Indoles; Inflammasomes; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Melatonin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitochondria; Nitric Oxide; Oxazoles; Random Allocation; Reactive Oxygen Species; Shock, Septic; Signal Transduction; Tumor Necrosis Factor-alpha

2015
PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1.
    Atherosclerosis, 2015, Volume: 240, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; beta-Defensins; Cell Line; Culture Media, Conditioned; Dose-Response Relationship, Drug; Fenofibrate; Gemfibrozil; Inflammation; Inflammation Mediators; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Oxazoles; PPAR alpha; RNA Interference; Signal Transduction; Toll-Like Receptor 4; Transfection; Tyrosine; Up-Regulation

2015
Synthesis and Biological Evaluation of N-Aryl-5-aryloxazol-2-amine Derivatives as 5-Lipoxygenase Inhibitors.
    Chemical & pharmaceutical bulletin, 2015, Volume: 63, Issue:8

    Topics: Amines; Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Line; Ear; Edema; Humans; Inflammation; Lipoxygenase Inhibitors; Mice; Oxazoles; Structure-Activity Relationship

2015
Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
    Pharmacological research, 2016, Volume: 107

    Topics: Adipocytes; Adiponectin; Cell Line; Cell Movement; Cell Survival; Chemokine CCL2; Chemokine CXCL10; Gene Expression Regulation; Glucose; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Interleukin-6; Lipid Metabolism; Oxazoles; p38 Mitogen-Activated Protein Kinases; PPAR alpha; PPAR gamma; Thiophenes; Tumor Necrosis Factor-alpha

2016
2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation.
    Pharmacological research, 2016, Volume: 108

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Coffee; Disease Models, Animal; Hyperalgesia; Inflammation; Male; Oxazoles; Peroxidase; Rats; Rats, Sprague-Dawley

2016
Inhibitory effect of estrogen receptor beta on P2X3 receptors during inflammation in rats.
    Purinergic signalling, 2017, Volume: 13, Issue:1

    Topics: Animals; Estrogen Receptor beta; Estrogens; Female; Hyperalgesia; Inflammation; Nitriles; Oxazoles; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X3

2017
15-deoxy-delta 12,14-prostaglandin J(2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation.
    Journal of cellular physiology, 2008, Volume: 217, Issue:2

    Topics: Acute-Phase Proteins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Cartilage; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Diclofenac; Dinoprostone; Down-Regulation; Enzyme Induction; Enzyme Repression; Imidazoles; Inflammation; Intramolecular Oxidoreductases; Lipocalin-2; Lipocalins; Lipopolysaccharides; Mice; NF-kappa B; Oncogene Proteins; Oxazoles; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; PPAR alpha; PPAR gamma; Prostaglandin D2; Prostaglandin-E Synthases; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Time Factors; Tyrosine

2008
Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain.
    British journal of pharmacology, 2008, Volume: 155, Issue:8

    Topics: Amidohydrolases; Analgesia; Animals; Benzamides; Carbamates; Carrageenan; Disease Models, Animal; Inflammation; Oxazoles; Pain; Piperidines; PPAR gamma; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Tyrosine

2008
Chinese prescription kangen-karyu ameliorates the development of diabetic hepatic damages via regulating oxidative stress and inflammation in the liver of db/db mice.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cyclooxygenase Inhibitors; Diabetes Complications; Drugs, Chinese Herbal; Glucose; Hyperglycemia; Inflammation; Inflammation Mediators; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase Type II; Oxazoles; Oxidative Stress; Phytotherapy

2011
Novel compound SK-1009 suppresses interleukin-6 expression through modulation of activation of nuclear factor-kappaB pathway.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:12

    Topics: Anti-Inflammatory Agents; Cell Line, Tumor; Colonic Neoplasms; Humans; I-kappa B Proteins; Inflammation; Inflammation Mediators; Interleukin-6; Isoindoles; Macrophages; NF-kappa B; Oxazoles; RNA, Messenger; Signal Transduction

2012
Study on SSAO enzyme activity and anti-inflammatory effect of SSAO inhibitors in animal model of inflammation.
    Journal of neural transmission (Vienna, Austria : 1996), 2013, Volume: 120, Issue:6

    Topics: Amine Oxidase (Copper-Containing); Animals; Arthritis, Experimental; Carrageenan; Disease Models, Animal; Enzyme Inhibitors; Functional Laterality; Gene Expression Regulation, Enzymologic; Hydrazines; Inflammation; Male; Oxazoles; Oximes; Rats; Rats, Wistar; Time Factors

2013
Preliminary screening of some new oxadiazol-2-ols with special reference to their antipyretic, analgesic, and anti-inflammatory properties. V.
    Arzneimittel-Forschung, 1963, Volume: 13

    Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Antipyretics; Humans; Inflammation; Oxazoles

1963
[DERIVATIVES OF BIPHENYL, STILBENE, DIPHENYLETHANE AND DIPHENYL ETHER WITH PRESUMED ANTI-INFLAMMATORY ACTIVITY].
    Il Farmaco; edizione scientifica, 1963, Volume: 18

    Topics: Anti-Inflammatory Agents; Biphenyl Compounds; Chemistry, Pharmaceutical; Ethers; Inflammation; Oxazoles; Phenyl Ethers; Research; Stilbenes

1963
[THERAPEUTIC VALUE OF OXOLAMINE CITRATE IN PEDIATRICS. A NEW ANTI-INFLAMMATORY SUBSTANCE].
    Gazette medicale de France, 1964, Dec-10, Volume: 71

    Topics: Anti-Inflammatory Agents; Biomedical Research; Child; Drug Therapy; Humans; Infant; Inflammation; Oxadiazoles; Oxazoles; Pediatrics; Toxicology

1964
IKKbeta phosphorylates p65 at S468 in transactivaton domain 2.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:12

    Topics: Active Transport, Cell Nucleus; Animals; Binding Sites; Blotting, Western; Cell Line; Cell Line, Tumor; Cells, Cultured; DNA Mutational Analysis; Fibroblasts; Genes, Dominant; Genes, Reporter; HeLa Cells; Humans; I-kappa B Kinase; Immunoprecipitation; Inflammation; Interleukin-1; Leukocytes, Mononuclear; Marine Toxins; Mice; Mice, Transgenic; Microscopy, Fluorescence; Mutagenesis, Site-Directed; Mutation; Oxazoles; Phosphorylation; Plasmids; Protein Structure, Tertiary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Transcription Factor RelA; Transcriptional Activation; Transfection; Tumor Necrosis Factor-alpha

2005
An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.
    European journal of pharmacology, 2006, Dec-28, Volume: 553, Issue:1-3

    Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor beta; Fulvestrant; Hot Temperature; Hyperalgesia; Inflammation; Male; Oxazoles; Pain; Rats; Rats, Sprague-Dawley

2006
Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes.
    Journal of immunology (Baltimore, Md. : 1950), 2008, Jan-01, Volume: 180, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Cytokines; Down-Regulation; Estrogen Receptor beta; Gene Expression Profiling; Humans; Inflammation; Leukocytes, Mononuclear; Oligonucleotide Array Sequence Analysis; Oxazoles; Selective Estrogen Receptor Modulators; Transcription, Genetic; Tumor Necrosis Factor-alpha

2008
Gelatin hydrogels: enhanced biocompatibility, drug release and cell viability.
    Journal of materials science. Materials in medicine, 2008, Volume: 19, Issue:6

    Topics: 3T3 Cells; Animals; Biocompatible Materials; Cell Survival; Cross-Linking Reagents; Drug Delivery Systems; Gelatin; Glutaral; Glyoxylates; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Hydrogen-Ion Concentration; Inflammation; Mice; Oxazoles; Polyamines; Polymers

2008
Estrogen receptor beta: expression profile and possible anti-inflammatory role in disease.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:1

    Topics: Animals; Asthma; Cells, Cultured; Estrogen Receptor beta; Gene Expression Profiling; Humans; Inflammation; Inflammation Mediators; Male; Oxazoles; Rats; Rats, Inbred BN; RNA, Messenger

2008
Pharmacological comparison of the immune and non-immune inflammations induced by picryl chloride and oxazolone in mice.
    Archives internationales de pharmacodynamie et de therapie, 1984, Volume: 269, Issue:1

    Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Dermatitis, Contact; Hypersensitivity, Delayed; Inflammation; Irritants; Kinetics; Male; Mice; Oxazoles; Oxazolone; Picryl Chloride

1984
Synthesis and topical antiinflammatory activity of some steroidal [16 alpha, 17 alpha-d]Isoxazolidines.
    Journal of medicinal chemistry, 1982, Volume: 25, Issue:12

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chemical Phenomena; Chemistry; Croton Oil; Glucocorticoids; Inflammation; Isoxazoles; Mice; Oxazoles

1982
Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration.
    Journal of applied physiology (Bethesda, Md. : 1985), 1998, Volume: 84, Issue:5

    Topics: Alkaloids; Animals; Azepines; Capillary Permeability; Carbazoles; Cattle; Cell Adhesion; Cell Movement; Cells, Cultured; Chemotactic Factors; Cyclic AMP-Dependent Protein Kinases; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Indoles; Inflammation; Leukotriene B4; Marine Toxins; Muscle, Smooth, Vascular; Myosin-Light-Chain Kinase; Naphthalenes; Neutrophils; Oxazoles; Phosphorylation; Pulmonary Artery

1998
Differential regulation of tumor necrosing factor-alpha (TNF-alpha) and interleukin-10 (IL-10) secretion by protein kinase and phosphatase inhibitors in human alveolar macrophages.
    European cytokine network, 1999, Volume: 10, Issue:2

    Topics: Cells, Cultured; Enzyme Inhibitors; Gene Expression Regulation; Humans; Inflammation; Interleukin-10; Lipopolysaccharides; Macrophages, Alveolar; Marine Toxins; Oxazoles; Phosphoprotein Phosphatases; Protein Kinase C; Protein Kinase Inhibitors; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

1999
JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2000, Volume: 49, Issue:3

    Topics: Animals; Benzenesulfonates; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Edema; Foot; Gastric Mucosa; Inflammation; Isoenzymes; Macrophages, Peritoneal; Male; Oxazoles; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Sprague-Dawley; Thromboxane B2

2000
The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
    Journal of neuroimmunology, 2000, Aug-01, Volume: 108, Issue:1-2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Anti-Inflammatory Agents; Cell Division; Cells, Cultured; Central Nervous System; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Humans; Inflammation; Interferon-gamma; Interleukin-5; Lymphocyte Activation; Mice; Mice, Inbred Strains; Multiple Sclerosis; Oxazoles; Rats; Rats, Inbred Lew; Recurrence; Spleen; Substrate Specificity; Th1 Cells; Th2 Cells; Tumor Necrosis Factor-alpha

2000
Vascular permeability and lymphoblast extravasation into inflamed skin are not related.
    Cellular immunology, 1977, Volume: 33, Issue:1

    Topics: Animals; Capillary Permeability; Cell Movement; Female; Inflammation; Male; Mice; Mice, Inbred BALB C; Neutrophils; Oxazoles; Oxazolone; Reserpine; Serotonin

1977
The anti=inflammatory properties of isoxicam (4-hydroxy-2methyl-N-(5-methyl-3isoxolyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide).
    Agents and actions, 1975, Volume: 5, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Carrageenan; Inflammation; Isoxazoles; Male; Oxazoles; Peptic Ulcer; Piroxicam; Rats; Thiazines

1975
Effects of cyclooxygenase and lipoxygenase inhibitors on inflammation associated with oxazolone-induced delayed hypersensitivity.
    Biochemical pharmacology, 1988, Sep-15, Volume: 37, Issue:18

    Topics: Animals; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Female; Hypersensitivity, Delayed; Inflammation; Leukotriene B4; Lipoxygenase Inhibitors; Mice; Oxazoles; Oxazolone; Prostaglandins E; SRS-A

1988
6-Sulfanilamidoindazole arthritis in rats: influence of the new anti-inflammatory agent CGP 28237 and of the immunomodulating compound HWA 486 on degree of arthritis and on acute phase reaction.
    Die Pharmazie, 1988, Volume: 43, Issue:1

    Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Indans; Indenes; Inflammation; Isoxazoles; Leflunomide; Oxazoles; Rats; Sulfanilamides

1988
Inflammatory lymphoid cells. Cells in immunized lymph nodes that move to sites of inflammation.
    Immunology, 1972, Volume: 22, Issue:3

    Topics: Aluminum Hydroxide; Animals; Antigens; Ascitic Fluid; Cell Movement; Chromium Isotopes; Croton Oil; Dermatitis, Contact; Freund's Adjuvant; Hypersensitivity, Delayed; Immune Tolerance; Immunization; Inflammation; Injections, Intravenous; Lymph Nodes; Lymphocyte Transfusion; Lymphocytes; Male; Mice; Mineral Oil; Oxazoles; Picryl Chloride; Polysaccharides, Bacterial; Skin Transplantation; Streptococcus pneumoniae; Transplantation, Homologous

1972
Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.
    Immunology, 1972, Volume: 23, Issue:4

    Topics: Animals; Antigens; B-Lymphocytes; Cyclophosphamide; Dermatitis, Contact; Guinea Pigs; Immunity, Cellular; Inflammation; Lymph Nodes; Lymphoid Tissue; Nitrobenzenes; Oxazoles; Passive Cutaneous Anaphylaxis; Skin Tests; Solubility; Spleen; Splenectomy; T-Lymphocytes; Transplantation, Homologous; Turpentine

1972
The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agent.
    Pharmacology, 1973, Volume: 9, Issue:3

    Topics: Adjuvants, Immunologic; Albumins; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Benzoxazoles; Blood Proteins; Bradykinin; Carrageenan; Diuretics; Fibrinogen; Globulins; Guinea Pigs; In Vitro Techniques; Inflammation; Male; Oxazines; Oxazoles; Rats; Stomach Ulcer; Time Factors

1973
Influence of nonsteroid anti-inflammatory agents on protein synthesis and hyperplasia caused by a tumor promoter.
    Journal of the National Cancer Institute, 1974, Volume: 52, Issue:6

    Topics: Acetates; Alcohols; Animals; Anti-Inflammatory Agents; Carcinogens; Cytosol; Diterpenes; Fatty Acids; Female; Hyperplasia; Inflammation; Methylcholanthrene; Oxazines; Oxazoles; Oxyphenbutazone; Precancerous Conditions; Protein Biosynthesis; Skin

1974
Competition between skin-sensitizing chemicals in the mouse.
    Immunology, 1974, Volume: 27, Issue:1

    Topics: Animals; Antibody Formation; Antigen-Antibody Reactions; Dermatitis, Contact; Female; Hypersensitivity, Delayed; Inflammation; Male; Mice; Oxazoles; Picryl Chloride; Skin Tests; Time Factors; Turpentine

1974
[Biological properties of 1,2-benzisothiazole compounds. On some pharmacological characteristics of benzisoxazolone and of benzisothiazolone].
    Bollettino della Societa italiana di biologia sperimentale, 1971, May-30, Volume: 47, Issue:10

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Body Temperature; Inflammation; Mice; Oxazoles; Phenylbutazone; Rats; Salicylamides; Thiazoles

1971
Wy 23205, a new non-steroidal anti-inflammatory agent.
    British journal of pharmacology, 1971, Volume: 42, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Arthritis; Aspirin; Bradykinin; Gastrointestinal Diseases; Guinea Pigs; Hindlimb; In Vitro Techniques; Indomethacin; Inflammation; Oxazoles; Phenylbutazone; Propionates; Rats

1971
[Pharmacological studies of oxazoleazepam, a new psychotropic agent. II. General pharmacology and subacute toxicity].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1970, Volume: 66, Issue:1

    Topics: Animals; Benzazepines; Blood Pressure; Body Temperature; Body Weight; Cats; Chlordiazepoxide; Chlorides; Constipation; Dogs; Electrocardiography; Female; Guinea Pigs; Heart Atria; Heart Rate; Humans; In Vitro Techniques; Inflammation; Injections, Intraperitoneal; Injections, Intravenous; Intestine, Small; Male; Nictitating Membrane; Oxazoles; Potassium; Pupil; Rabbits; Respiration; Sodium; Substance-Related Disorders; Tranquilizing Agents; Urination; Uterus

1970